Acasti Pharma U.S., Inc.
Records under this name other than the patents Acasti Pharma U.S., Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Showing 1 to 7 of 7 · Back to Acasti Pharma U.S., Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,586,567 | Concentrated Therapeutic Phospholipid Compositions Formerly held In force · High confidence | In force | High confidence | |
| US 9,475,830 | Concentrated Therapeutic Phospholipid Compositions Formerly held In force · High confidence | In force | High confidence | |
| US 10,130,644 | Concentrated Therapeutic Phospholipid Compositions Formerly held In force · High confidence | In force | High confidence | |
| US 12,194,064 | Process of producing concentrated therapeutic phospholipid composition from krill extracts containing high level of free fatty acids Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,414,943 | Nimodipine parenteral administration Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,326,922 | Apparatus for metering and dispensing viscous substance Formerly held Lapsed on the fee record Ended May 10, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 10, 2026 | From the USPTO record |
| US 10,617,702 | Concentrated Therapeutic Phospholipid Compositions Formerly held Lapsed on the fee record Ended Apr 14, 2024 · Medium confidence | Lapsed on the fee record | Ended Apr 14, 2024 | Medium confidence |